Results 111 to 120 of about 8,347 (150)

Neurological paraneoplastic syndromes: an update

Current Opinion in Oncology, 2018
Purpose of review To describe recent advances in the diagnosis and treatment of paraneoplastic neurological syndromes (PNS). Recent findings PNS are rare complications of cancer caused by an immune cross-reaction between antigens expressed by tumor cells and neurons.
Berzero G., Psimaras D.
openaire   +3 more sources

The immunopathogenesis of paraneoplastic neurological syndromes

Clinical Science, 2002
Paraneoplastic neurological syndromes are rare non-metastatic complications of cancer that have an immune-mediated aetiology. The central and peripheral nervous systems are considered to be immune-privileged sites, since the presence of the ‘blood-brain/nerve barrier’ means that antigens sequestered within the nervous system do not normally induce an ...
Ian, Sutton, John B, Winer
openaire   +2 more sources

Update on paraneoplastic neurological syndromes

Current Opinion in Oncology, 2009
To describe specificities and new advances in treatment of paraneoplastic neurological syndromes (PNS).PNS are defined as neurological syndromes of unknown cause that often antedate the diagnosis of an underlying cancer that is usually not clinically evident.
Adrien, Didelot, Jérôme, Honnorat
openaire   +2 more sources

Diagnostics of paraneoplastic neurological syndromes

Neurological Sciences, 2017
This document presents the guidelines for onconeural antibody testing that have been developed following a consensus process built on questionnaire-based surveys, internet contacts, and discussions at workshops of the sponsoring Italian Association of Neuroimmunology (AINI) congresses.
Zoccarato, Marco, Gastaldi, Matteo, Zuliani, Luigi, Biagioli, Tiziana, Brogi, Marco, Bernardi, Gaetano, Corsini, Elena, Bazzigaluppi, Elena, Fazio, Raffaella, Giannotta, Claudia, Nobile-Orazio, Eduardo, Costa, Gianna, Iorio, Raffaele, Evoli, Amelia, Mariotto, Sara, Ferrari, Sergio, Galloni, Elisabetta, De Riva, Valentina, Zardini, Elisabetta, Franciotta, Diego, Giometto, Bruno   +20 more
openaire   +4 more sources

Paraneoplastic neurologic syndromes

Current Neurology and Neuroscience Reports, 2006
Paraneoplastic neurologic disorders (PND) are remote medical complications of cancer that cannot be attributed to direct effects of the neoplasm or its metastases. PND are uncommon, disabling syndromes that have been recognized for more than 50 years.
openaire   +2 more sources

Autonomic paraneoplastic neurological syndromes

Autoimmunity Reviews, 2007
Autonomic paraneoplastic neurological syndromes (PNS) typically present as chronic gastrointestinal pseudo-obstruction or orthostatic hypotension and usually occur in association with other PNS rather than in isolation. Although rare, they are often debilitating, sometimes fatal, and probably seriously underdiagnosed.
LORUSSO L, HART IK, FERRARI D, NGONGA GK, GASPARETTO C, RICEVUTI, GIOVANNI   +5 more
openaire   +3 more sources

Paraneoplastic neurological syndromes

Current Opinion in Neurology, 2002
This review discusses recent advances and current controversies in the aetiology, investigation and management of paraneoplastic neurological syndromes.Antibody studies continue to define potential target autoantigens in paraneoplastic neurological syndromes and although pathogenic activity has been demonstrated for anti-glutamate receptor antibodies ...
openaire   +2 more sources

Advances in paraneoplastic neurological syndromes

Current Opinion in Oncology, 2004
To describe specificities and new advances in paraneoplastic neurologic syndromes (PNSs).Paraneoplastic neurologic syndromes are defined as neurologic syndromes of unknown cause that often antedate the diagnosis of an underlying, usually not clinically evident, cancer.
Jérôme, Honnorat, Stéphanie, Cartalat-Carel   +1 more
openaire   +2 more sources

Diagnosis and Treatment of Paraneoplastic Neurological Syndromes

Current Clinical Pharmacology, 2008
Paraneoplastic neurological syndromes (PNS) are remote effects of cancer that may involve any part of the nervous system. Rarity hinders their diagnosis and management and at least 60% of cases do not present a tumor at neurological symptoms onset. An important diagnostic element is detection, in patients' serum or cerebrospinal fluid, of onconeuronal ...
Vitaliani R, Zoccarato M, Giometto B
openaire   +5 more sources

Autoantibodies in Paraneoplastic Neurological Syndrome

The American Journal of the Medical Sciences, 2000
Paraneoplastic neurological syndrome is a rare disorder caused by the secondary effects of cancer and is thought to be immune-mediated. A high titer of autoantibodies in the patient's serum and cerebrospinal fluid, directed against both neurons and tumor, have been detected in some forms of this syndrome.
openaire   +2 more sources